BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 30054238)

  • 1. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
    Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
    Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
    Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418).
    Yoo GS; Park W; Yu JI; Choi DH; Kim YJ; Shin KH; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
    Cancer Res Treat; 2019 Jul; 51(3):1041-1051. PubMed ID: 30384580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
    Xia LY; Xu WY; Hu QL
    PLoS One; 2021; 16(9):e0256893. PubMed ID: 34473783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-conserving surgery in early-stage breast cancer (indications, local recurrences, survival, cosmetic results).
    Mitov FS; Molov VV
    Folia Med (Plovdiv); 2006; 48(1):23-30. PubMed ID: 16918051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
    Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
    Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of breast-conserving surgery and mastectomy in early breast cancer using observational data revisited: a propensity score-matched analysis.
    Chen K; Pan Z; Zhu L; Hu T; Peng M; Jia W; Su F; Li S; Song E
    Sci China Life Sci; 2018 Dec; 61(12):1528-1536. PubMed ID: 30443859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
    Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
    Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
    Sun GY; Wen G; Zhang YJ; Tang Y; Jing H; Wang JY; Zhang JH; Yang Y; Zhao XR; Chen SY; Jin J; Song YW; Liu YP; Fang H; Ren H; Tang Y; Qi SN; Li N; Chen B; Lu NN; Wang SL; Li YX
    BMC Cancer; 2020 Nov; 20(1):1155. PubMed ID: 33243177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Gwark S; Kim HJ; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Lee SB
    Ann Surg Oncol; 2023 May; 30(5):2845-2853. PubMed ID: 36577865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort?
    Voordeckers M; Van de Steene J; Vinh-Hung V; Storme G
    Radiother Oncol; 2003 Sep; 68(3):227-31. PubMed ID: 13129629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.